Introduction
Titration experiments where gene expressions in two different tissues are measured together with total RNA mixtures of the pure samples provide experimental data for the evaluation of quality related aspects of microarray data (MAQC consortium, 2006; Holloway et al., 2006) . Such experiments operate on the assumption that for any RNA fragment the abundances in the mixture samples can be determined as a function of their expression in the pure samples and the given mixture proportions. Monotonic mixture proportions imply that the measured RNA fragment abundances follow a monotonic trend of unspecified functional form across the titration series. This allows us to employ order restricted analysis methods leading to more accurate estimates and more powerful testing procedures compared to unrestricted alternatives. Furthermore, we can investigate if the postulated order structure is actually present in the data. Titration experiments that cover several commercial microarray platforms often also incorporate several grouping factors that lead to a complex hierarchical variance structure. We therefore express the problem in terms of a linear mixed effects model with order restrictions and consider methods that can accommodate for such variance structures. Based on this framework we derive quality metrics that quantify accuracy and repeatability of microarray measurements as well as agreement of test decisions across different measurement platforms.
Methods
We present our methods along the lines of a large scale titration experiment published by the EMERALD project 1 . The probe material used in this experiment was harvested from six rats. Total RNA was extracted from livers and kidneys of these rats. The resulting sample material was then prepared in four mixtures:
1. pure liver material, which we will refer to as L, 2. 75% liver mixed with 25% kidney material, which we will call M1, 3. 25% liver and 75% kidney, in the following simply M2, 4. pure kidney material, which is denoted as K.
This yielded four times six batches of sample material each of which was labeled and hybridized to three arrays from each of three different commercial microarray platforms. In summary this amounts to: 3 platforms × 6 rats × 4 mixes × 3 replicates = 216 arrays.
The use of genetically different animals implies that beside the noise generated by the imprecision of the measurement technology there is variation due to genetic differences between the animals. This variance structure generated by the experimental design can be directly translated into a mixed model definition which is assumed for each probe separately. Based on this model we compute measures for accuracy, repeatability and across platform agreement for this dataset. Furthermore we consider two normalization procedures (baseline and quantile normalization (Gentleman et al., 2005) ) and investigate if the normalized data better complies with the monotonicity assumption or if it introduces artifacts that may lead to non-monotonous trends. First, we test consecutive differences between mixture groups for a significant increase or decrease in expression for each gene. We construct permutation tests accounting for the specific hierarchical variance structure (Pesarin, 2001 ) of the EMERALD data set and adjust for multiple testing using a novel procedure that accounts also for directional errors (Guo et al., 2009 ). Thereby we can identify any significant deviation from the monotonicity assumption which would be in violation of the implications of the study design. Secondly, we investigate the variance components of the data. For that purpose the total variance of the data is decomposed into components that can be attributed to either systematic variation (e.g. noise emanating from imperfections in the study design or genetic differences between individuals) and residual error which serves as an estimate of the imprecision of the platform. For this task we developed a novel method to estimate such variance components under order restrictions. It uses information from monotonic regression (Barlow, 1972) to retain degrees of freedom by pooling consecutive groups that violate the order restriction. Our simulations show that this method achieves considerable improvement of the estimates in terms of mean squared error. Finally, we raise the topic of cross platform agreement in terms of the correspondence of differential expression analysis across the measurement technologies. Differential expression between the two different organ materials introduces a monotonous trend across the titration series. We derive an inference procedure based on isotonic regression and permutation based multiple testing methods (Westfall and Young, 1993) to test the null hypothesis of no differential expression for each gene of a well annotated set of common genes found on each platform.
Results
Results from an application to the EMERALD dataset demonstrate how our methods provide easily interpretable quality metrics that are on par with results from previous work on titration experiments but also provide new insights, especially, in regard to the investigated normalization procedures. Titration experiments are designed with the aim to produce authentic biological data with a proportion of differentially expressed genes that is larger than what can be simulated using spike-in experiments. Thereby they pose an interesting challenge to the evaluation of such procedures. This is due to often held assumptions, namely that the truly differentially expressed genes are relatively few and balanced in terms of direction (Stafford, 2008, chap. 2), being violated by the measurements generated in such experiments. Under these premises they provide an opportunity to study the robustness of such procedures against violations of their corresponding assumptions. Our results from the EMERALD dataset highlight some of the pitfalls of microarray data analysis and subsequent interpretation. First of all we observe that expression values from kidney material are on average higher than those from liver material resulting in a disproportionate amount of upward trends across the titration series. It is unclear whether this large proportion of upward trends is a biological feature or a procedural artifact. We speculate that the concentration of mRNA in the total RNA samples from the liver samples is lower than that in the kidney samples. This hypothesis would be a good explanation for many aspects of the data. Considering this assumption baseline and quantile normalization would appear to be good candidates as methods to remove such a trend. Our results show, however, that the performance of neither baseline nor quantile normalization is convincing in the case of the EMERALD dataset. On the one hand normalization does slightly reduce the observed residual errors and hence lead to improved repeatability and more powerful differential expression inference. On the other hand an increase in non-monotonous trends, which are contrary to the intrinsic implications of the study design, show that accuracy is degraded by these procedures. Furthermore the agreement of differential expression across different microarray platforms is also deteriorated when normalized data are considered. We conclude that compared to these two widely applied preprocessing procedures non-normalized data does provide better accuracy and agreement with only a slight disadvantage in terms of repeatability. Unfortunately, we are unable to check whether this result is specific to the EMERALD dataset, since, to our knowledge, non-normalized data have not been considered in comparable titration based microarray evaluations.
